Metabolic Biomarkers in Thoracic Cancers Study

This study is looking at new ways to use magnetic resonance imaging (MRI) to examine lung tumors and other cancers in the chest area. Researchers want to see how these tumors use sugar for growth. They will use a special sugar solution called 13C-glucose and then study a small sample of the tumor after it's removed during surgery. The goal is to find better ways to detect cancer and help doctors decide on the best treatment plan. You might be able to join if you are over 18, need surgery for a suspected cancer in your chest, and do not have poorly controlled diabetes. The study aims to enroll 200 participants, but its current recruitment status is unclear.

Study design
This is an interventional study planning to enroll 200 participants. It is not specified if it is randomized or blinded.
What's involved
You would undergo an MRI scan using 13C-glucose within 5 days of your scheduled surgery. A small sample of your tumor will be studied after surgery.
Compensation
Not stated in the trial record.
Follow-up
Your DCE-MRI will be measured at one time, within 5 days of your scheduled surgery.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT02095808

Metabolic Biomarkers in Thoracic Cancers

Recruiting
NAAges 18+InterventionalBasic science
University of Texas Southwestern Medical Center
~200 participants
Updated 2026-05-01 on ClinicalTrials.gov
What's tested:Imaging Biomarkers

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
DCE-MRI
Measured over One time - within 5 days of the scheduled surgery
Lung Cancer
1 sites across 1 states
Texas1
  • Kemp H Kernstine, MD · PRINCIPAL_INVESTIGATOR · University of Texas Southwestern Medical Center

Opens a ready-to-send draft in your own email app — review before sending.

  • DCE-MRIOne time - within 5 days of the scheduled surgery

    Physicians and researchers will review the results of the imaging to determine if the patient will receive the \[U-13C\] glucose infusion.